Armata Pharmaceuticals, Inc. (FRA:TG1N)

Germany · Delayed Price · Currency is EUR

6.65

+0.40 (6.40%)

At close: Jan 9, 2026

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2003 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2003 - 2019
Pathogen-specific Bacteriophage Therapeutics	5.17M	Log In	Log In	Log In	Log In	Upgrade
Pathogen-specific Bacteriophage Therapeutics Growth	14.24%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2003 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2003 - 2019
United States and Australia	5.17M	Log In	Log In	Log In	Log In	Upgrade
United States and Australia Growth	14.24%	Log In	Log In	Log In	Log In	Upgrade